Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05882253 · ClinicalTrials.gov registry record · NA
Prostate Cancer IMAGing IN Early Detection (IMAGINED Trial)
A NA study of Prostate Cancer, sponsored by University of California, San Diego.
- Recruiting
- Registry status
- NA
- Development phase
- 225
- Enrollment target
- 1
- Study location
NCT05882253 is a NA study of Prostate Cancer that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 225 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05882253, a NA study of Prostate Cancer, is actively recruiting participants, sponsored by University of California, San Diego.
- RECRUITING
- Registry status
- NA
- Development phase
- 225 participants
- Enrollment target
- 1
- Study location
Study Summary
The researchers hope to learn if specific types of MRI software and techniques can help improve early prostate cancer detection at time of a MRI-guided prostate biopsy.
Conditions Studied
Interventions
- OTHER Restricted Spectrum Imaging-Magnetic Resonance Imaging (RSI-MRI)
Study Locations (1)
California
- University of California, San Diego - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 225 participants |
| Start Date | 2023-12-04 |
| Est. Completion | 2028-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05882253
The ClinicalTrials.gov registry entry for NCT05882253 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 225 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (63% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Restricted Spectrum Imaging-Magnetic Resonance Imaging (RSI-MRI) is the first listed.
NCT05882253 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05882253 about?
NCT05882253 is a clinical study titled "Prostate Cancer IMAGing IN Early Detection (IMAGINED Trial)". The researchers hope to learn if specific types of MRI software and techniques can help improve early prostate cancer detection at time of a MRI-guided prostate biopsy.
What is the current status of trial NCT05882253?
This trial is currently recruiting. It is a NA study. The enrollment target is 225 participants. The study started on 2023-12-04. Estimated completion is 2028-04.
What conditions does trial NCT05882253 study?
This clinical trial studies the following conditions: Prostate Cancer.
What interventions are being tested in trial NCT05882253?
The interventions under investigation include: Restricted Spectrum Imaging-Magnetic Resonance Imaging (RSI-MRI) (OTHER).
Who is sponsoring clinical trial NCT05882253?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05882253 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
RECRUITING · NA
-
Diffusion Basis Spectrum Imaging of the Prostate
RECRUITING · NA
-
Micro-UltraSound In Cancer - Active Surveillance
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
SBRT Boost for Unfavorable Prostate Cancer'
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.